Rasmussen's encephalitis: Early characteristics allow diagnosis

Neurology

Volumn 60, Issue 3, 2003, Pages 422-425

  Granata, Tiziana ^a   Gobbi, G ^b   Spreafico, R ^a   Vigevano, F ^c   Capovilla, G ^d   Ragona, F ^a   Freri, E ^a   Chiapparini, L ^a   Bernasconi, P ^a   Giordano, L ^e   Bertani, G ^f   Casazza, M ^a   Bernardina, B Dalla ^g   Fusco, L ^c  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d CARLO POMA HOSPITAL   (Italy)

^e Ospedali Civili   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g POLICLINICO BORGO ROMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PROTEIN ANTIBODY; PROTEIN GLUR3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; HUMAN; IMMUNOASSAY; MALE; NEUROPATHOLOGY; NEUROSURGERY; PRIORITY JOURNAL; RASMUSSEN SYNDROME; WHITE MATTER;

EID: 0037432041     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.3.422     Document Type: Article

References (14)

1. Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8:435-445.
2. Rasmussen T, Andermann F. Rasmussen's syndrome: symptomatology of the syndrome of chronic encephalitis and seizures: 35-year experience with 51 cases. In: Lüders H, ed. Epilepsy surgery. New York: Raven Press, 1991;173-178.
3. Vining EP, Freeman JM, Brandt J, Carson BS, Uematsu S. Progressive unilateral encephalopathy of childhood (Rasmussen's syndrome): a reappraisal. Epilepsia 1993;34:639-650.
4. Robitaille Y. Neuropathologic aspects of chronic encephalitis. In: Andermann F, ed. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Boston: Butterworth-Heinemann, 1991;79-110.
5. Andrews JM, Thompson JA, Pysher TJ, Walker ML, Hammond ME. Chronic encephalitis, epilepsy, and cerebrovascular immune complex deposits. Ann Neurol 1990;28:88-90.
6. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265: 648-651.
7. Hart YM, Cortez M, Andermann F, et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994;44:1030-1036.
8. McLachlan RS, Levin S, Blume WT. Treatment of Rasmussen's syndrome with ganciclovir. Neurology 1996;47:925-928.
9. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO. Plasmapheresis in Rasmussen's encephalitis. Neurology 1996;46:242-246.
10. Antozzi C, Granata T, Aurisano N, et al. Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis. Neurology 1998; 51:302-305.
11. Mantegazza R, Bernasconi P, Baggi F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002;131:179-185.
12. Krauss GL, Campbell ML, Roche KW, Huganir RL, Niedermeyer E. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3. Neurology 1996;46:247-249.
13. Villani F, Spreafico R, Farina L, et al. Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 2001;56:248-250.
14. Wiendl H, Bien CG, Bernasconi P, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001;57:1511-1514.